1 of 60

OMICS ANALYSIS II

2 of 60

RNA-SEQ

  • RNA-Seq can reveal the quantity of RNAs in biological sample at a given moment and condition

​

3 of 60

4 of 60

APPLICATIONS OF RNA-SEQ

  • Alternative gene spliced transcripts
  • Gene fusion
  • Non-coding RNA
  • Quantification comparison

​

5 of 60

IDENTIFICATION AND QUANTIFICATION

  • Identification: Knowing the sequence composition of the DNA/RNA reads for alignment.
  • Quantification: Based on the alignment to calculate the amount of reads aligned at the genes.

ATAGACCGCGATA

Gene

Identification

Alignment

Quantification

6 of 60

COULD WE COMPARE THEM?

​

S.1

Gene 1

3

​

S.1

Gene 1

33

33-3=30

7 of 60

COULD WE COMPARE THEM?

​

S.1

Gene 1

3

Gene 2

5

Gene 3

0

Gene 4

8

Gene 5

1

Gene 6

4

​

S.1

Gene 1

33

Gene 2

23

Gene 3

3

Gene 4

43

Gene 5

10

Gene 6

5

All are higher

8 of 60

COULD WE COMPARE THEM?

​

S.1

S.2

S.3

Gene 1

3

4

3

Gene 2

5

7

10

Gene 3

0

0

0

Gene 4

8

4

8

Gene 5

1

2

2

Gene 6

4

4

5

​

S.1

S.2

S.3

Gene 1

33

3

5

Gene 2

23

3

8

Gene 3

3

0

1

Gene 4

43

4

4

Gene 5

10

1

2

Gene 6

5

5

7

S.1 has significant higher quantification

9 of 60

COULD WE COMPARE THEM?

​

S.1

S.2

S.3

Gene 1

3

4

3

Gene 2

5

7

10

Gene 3

0

0

0

Gene 4

8

4

8

Gene 5

1

2

2

Gene 6

4

4

5

​

S.1

S.2

S.3

Gene 1

23

23

25

Gene 2

3

3

8

Gene 3

3

0

1

Gene 4

4

4

4

Gene 5

2

1

2

Gene 6

6

5

7

Prot.1 has significant higher quantification

10 of 60

COULD WE COMPARE THEM?

​

S.1

S.2

S.3

Gene 1

3

4

3

Gene 2

5

7

10

Gene 3

0

0

0

Gene 4

8

4

8

Gene 5

1

2

2

Gene 6

4

4

5

​

S.1

S.2

S.3

Gene 1

23

3

5

Gene 2

3

3

8

Gene 3

3

0

1

Gene 4

4

4

4

Gene 5

2

1

2

Gene 6

6

5

7

Prot.1 at S.1 has significant higher quantification

11 of 60

NORMALIZATION

12 of 60

NORMALIZATION

13 of 60

NORMALIZATION

14 of 60

RPKM

  • If the length of a gene is longer, more reads can map on it.

15 of 60

NORMALIZATION

16 of 60

RPKM

Divided by the sum of counts within the sample

17 of 60

RPKM

Divided by exon length

18 of 60

FPKM

  • The idea of FPKM is the same as RPKM. FPKM is used for paired-end library and RPKM is for single-end library.
  • FPKM will count the paired reads for only one time.

Gene

Only count as 1

19 of 60

TPM

Divided by the gene length

20 of 60

TPM

Divided by the sum of counts within the sample from 1 step

21 of 60

COMPARING RPKM AND TPM

22 of 60

CORRELATION COEFFICIENT

23 of 60

CORRELATION COEFFICIENT

  • Pearson correlation coefficient
    • Linear model
  • Spearmann correlation coefficient
    • Non-linear model
    • Remove outliers
  • Euclidean distance
    • Distance based calculation
    • Value differences can be considered

24 of 60

CORRELATION COEFFICIENT OR�EUCLIDEAN DISTANCE

Correlation coefficient is based on the trend. In this case, the correlation coefficient will be nearly 100%.

Euclidean distance is based on the distance between two lines. In this case, Euclidean distance is still not small.

The key is “the amount is matter or not”.

25 of 60

QUANTIFICATION COMPARISON

26 of 60

DIFFERENTIAL EXPRESSION ANALYSIS

  • Differential expression analysis means taking the normalized read count data and performing statistical analysis to discover quantitative changes in expression levels between experimental groups.
  • It is the most widely used analysis method for comparative transcriptomics.
  • It is also often used for searching the biomarkers.

27 of 60

HER2 receptor

HER2 receptor

28 of 60

WHEN ARE TWO VALUES DIFFERENT

29 of 60

REPLICATES INCREASE RELIABILITY

  • More replicates, more reliable mean estimates

​

  • Define a fold change threshold ? Is it significant?

30 of 60

FOLD CHANGE NOT INFORMATIVE ENOUGH

  • The 3 proteins have the same fold change

​

  • Significance of protein B > signif. of protein A > signif. of protein C

31 of 60

T-TEST

  • Consider both variance between groups and variance within groups
  • Test-statistic:
  • p-value: how likely is it to get a certain value of t by chance
  • significant, if p-value <= significance level alpha, alpha = 0.01

 

32 of 60

P-VALUE

33 of 60

MULTIPLE HYPOTHESIS PROBLEM

  • Multiplicity problem:
    • 10,000 hypotheses are tested simultaneously
    • Increased chance of false positives

​

  • Suppose
    • none of the 10,000 proteins is differentially expressed
    • We expect 10,000 * 0.01 = 100 with p-value < 0.01

Individual p–values are no significant findings

34 of 60

BENJAMINI-HOCHBERG CORRECTION

  • Compute p-values of all tests (m=10)
  • Order them in increasing order

Test if:

​

34

 

 

Rank i

P-value

Adjusted significance level

? Reject H0

1

0.00002

0.001

yes

2

0.00013

0.002

yes

3

0.00034

0.003

yes

4

0.00087

0.004

yes

5

0.001

0.005

yes

6

0.0054

0.006

yes

7

0.009

0.007

no

8

0.01

0.008

no

9

0.023

0.009

no

10

0.4

0.01

no

Significance Level:

Adjusted Significance Level

35 of 60

PERMUTATION-BASED FDR

Compute test statistic & p-value

Permute data

Repeat many times

Control

Stimulus

Control

Stimulus

Compute test statistic & p-value

Protein A

Protein B

Protein C

Protein D

Protein E

MEASURED

PERMUTED

  • False discovery rate estimated by counting hits on permuted data

Careful with technical replicates !!!

36 of 60

VOLCANO PLOT

FDR cutoff at

Sign. Level 0.05

LogFC

-Log(q)

37 of 60

USING FOLD CHANGE

Difference

-log p

-log p

Difference

LogFC

-Log(q)

-Log(q)

LogFC

38 of 60

VOLCANO PLOT

The normal cutoff is

​

Q-value ≤ 0.05 which means

-log(q-value) ≥ ~1.3

​

Log2(FC) ≥ 1 ~ 2 or Log2(FC) ≤ -1 ~ -2

39 of 60

ENRICHMENT ANALYSIS

  • Fisher’s Exact Test
  • Gene Ontology
    • Biological process (GOBP)
    • Molecular function (GOMF)
    • Cellular component (GOCC)

Contingency table:

In pathway?

Significant ?

​

yes

no

yes

15

849

no

12

3,657

Is a particular pathway overrepresented in the set

of differentially expressed proteins?

Difference

-log p

Fatty acid metabolism

Significant

Non Significant

  • Pathways
    • KEGG

40 of 60

ENRICHMENT ANALYSIS

  • Fisher’s Exact Test

Difference

-log p

Fatty acid metabolism

Significant

Non Significant

Category column

Category value

Total size

Selection size

Category size

Intersection size

Enrichment factor

P value

Benj. Hoch. FDR

KEGG name

Fatty acid elongation in mitochondria

4533

864

6

6

5.25

4.73E-05

2.42E-03

KEGG name

Benzoate degradation

4533

864

8

7

4.59

5.81E-05

2.48E-03

GOCC name

organellar ribosome

4533

864

15

12

4.20

5.25E-07

4.36E-05

GOCC name

mitochondrial ribosome

4533

864

15

12

4.20

5.25E-07

4.76E-05

KEGG name

Valine, leucine and isoleucine degradation

4533

864

35

22

3.30

1.17E-08

3.00E-06

GOBP name

cellular hormone metabolic process

4533

864

21

13

3.25

1.56E-05

1.92E-03

GOBP name

fatty acid catabolic process

4533

864

32

19

3.12

4.18E-07

1.09E-04

KEGG name

Butanoate metabolism

4533

864

16

9

2.95

8.46E-04

1.55E-02

KEGG name

Fatty acid metabolism

4533

864

27

15

2.91

2.06E-05

1.32E-03

Contingency table:

In pathway?

Significant ?

​

yes

no

yes

15

849

no

12

3,657

Enrichment analysis on categorical data

LogFC

-Log(q)

41 of 60

ENRICHMENT ANALYSIS

42 of 60

MULTIPLE SAMPLE TEST

  • Two samples test
    • Treatment vs Control
  • Multiple sample test
    • Time serious
    • Drug treatment comparison
    • SNP comformation

43 of 60

1D ANNOTATION ENRICHMENT

All proteins

Do ribosomal proteins show preferentially higher abundances compared to all proteins?

0

200

400

600

800

12

Log2 (Protein intensities)

28

32

16

20

24

Ribosomal proteins

44 of 60

1D ANNOTATION ENRICHMENT

Enrichment analysis on numerical data

All proteins

  • Two-sample test
  • Benjamini Hochberg FDR
  • In addition: Rank-based score between -1 and 1

0

200

400

600

800

12

Log2 (Protein intensities)

28

32

16

20

24

Ribosomal proteins

Score = 2(R1-R2)/n = 0.85

45 of 60

EXAMPLE OF PCA

46 of 60

PRINCIPLE COMPONENT ANALYSIS

PCA – Linear model

tSNE – Non-linear model

UMAP – non-linear model

47 of 60

CO-EXPRESSION ANALYSIS

48 of 60

DIMENSIONALITY REDUCTION METHOD

49 of 60

CLUSTERING HEATMAP

50 of 60

SPLICE EVENT

51 of 60

GENE FUSION

52 of 60

NON-CODING RNA

53 of 60

NON-CODING RNA

54 of 60

EQTL:EXPRESSION QUANTITATIVE TRAIT LOCI ANALYSIS

55 of 60

RIBOSOME PROFILING

  • RNA-Seq based translomics
  • Detection and quantification of the RNAs which are under translation

56 of 60

57 of 60

APPLICATION OF RIBO-SEQ

  • Measuring protein synthesis
  • Identifying novel protein – small proteins
  • Working with ChIP-Seq to study cell regulation

58 of 60

DE NOVO SEQUENCING

  • Mapping the reads without reference sequences
  • Applications
    • Novel species
    • Paleo genome or proteome
    • Lacking correct sequence information

59 of 60

5. Using close species to generate annotations.

60 of 60

PALEO-GENOMICS